Cerulean Pharma

company

About

Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.

  • 1 - 10

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$26M
Industries
Biotechnology,Health Care,Nanotechnology,Therapeutics
Founded date
Jan 1, 2006
Number Of Employee
1 - 10
Operating Status
Active

Cerulean Pharma Inc. is a privately-held biopharmaceutical company focused on the development of novel nanotechnology-based therapeutics in the areas of oncology, cardiovascular, autoimmune and inflammatory diseases.

The Company has assembled a world-class management team, board of directors and scientific advisory board that collectively have a significant track record of business building, product development and scientific breakthroughs from companies and institutions such as Cubist, GlaxoSmithKline, Merck, Millennium Pharmaceuticals, Inc., Pfizer, Wyeth, the Massachusetts Institute of Technology, Harvard Medical School, MD Anderson, Fox Chase Cancer Center and the Arizona Health Center.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$26M
Cerulean Pharma has raised a total of $26M in funding over 2 rounds. Their latest funding was raised on Jan 9, 2015 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 9, 2015 Post-IPO Debt $26M 1 Hercules Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Cerulean Pharma is funded by 1 investors. Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Yes Post-IPO Debt